GRECO-2 Trial Could Show Promising Results for Pancreatic Cancer

Moffitt was one of the high-volume centers with the last trial, which showed improved outcomes. Moffitt researchers are hopeful that this current...

Percutaneous Hepatic Perfusion in Patients with Hepatic-dominant Ocular Melanoma

The analysis indicated that PHP demonstrated a statistically superior overall response rate and significantly prolonged progression-free survival in...

TVEC for the Treatment of Early Stage Triple Negative Breast Cancer

TVEC is designed to preferentially lyse tumor cells over normal tissue to release tumor associated antigens, produces GM-CSF to activate dendritic...

Reshaping the Frontline Treatment Landscape of ES-SCLC

Dr. Bruna Pellini, in an interview with OncLive®, also compares the findings of the CASPIAN and IMpower133 trials and research efforts currently...

Improving Representation of Racial and Ethnic Minorities in Lung Cancer Screening Programs

With recent screening guidelines changes, more people are eligible for a low-dose CT scan and have the ability to participate in lung screening...

Macrophage Tumor Cell Metabolic Interactions Induce Therapeutic Resistance in Prostate Cancer

Castration-resistant prostate cancer (CRPC) is a lethal stage of disease. A wealth of clinical and experimental data supports the persistence of...

In Silico Trial Estimates Personalized Radiation Therapy Dose in Head and Neck Cancer

By means of this unique in silico trial, we demonstrate a potential method to use historical clinical observations in conjunction with...

Circulating tumor DNA (ctDNA) MRD Detection from Plasma and Urine and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer

Tumor-naïve plasma ctDNA analysis can sensitively and specifically detect MRD in patients with oligometastatic CRC after neoadjuvant chemotherapy....

Pushing for a Cure: New Treatments for Head and Neck-Endocrine Cancer

Moffitt's Head and Neck-Endocrine Oncology Department discuss new treatments for Head and Neck and Endocrine cancers in this webinar and Q&A session.

Illustration of women health care workers

Moffitt Women Faculty: By the Numbers

Moffitt Cancer Center's women team members come from different backgrounds and cultures across the globe.

Head and Neck Cancer Vaccine Trial on the Horizon

While there currently are two approved immunotherapy treatments for head and neck cancers, only about 20% of patients respond. Vaccine trials like...

Novel Immunotherapy and Chemotherapy in Patients with Ovarian Cancer

Robert Wenham, MD, MS, FACOG, FACS, a gynecologic oncologist and chair of the Gynecologic Oncology Program at Moffitt Cancer Center, discusses novel...

Meet Our Endoscopic Endonasal and Skull Base Tumor Surgeon

We sat down with Moffitt’s newest faculty member on the Neuro-Oncology team, Dr. Andre Beer Furlan, to learn about his unique skills in endoscopic...

Our Commitment to Your Patients

When you refer a patient to Moffitt, they are connected with a healthcare professional the next day. Immediate attention means less anxiety. Quicker...